Table of Content
1. Introduction
1.1 Market Definition
1.2 Scope (Inclusion and Exclusions)
1.3 Research Assumptions
2. Executive Summary
2.1 Market Overview
2.2 Regional Synopsis
2.3 Competitive Summary
3. Research Methodology
3.1 Top-Down Approach
3.2 Bottom-up Approach
3.3. Data Validation
3.4 Primary Interviews
4. Market Dynamics Impact Analysis
4.1 Market Driving Factors Analysis
4.1.2 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
4.2 PESTLE Analysis
4.3 Porter’s Five Forces Model
5. Statistical Insights and Trends Reporting
5.1 Incidence and Prevalence (2023)
5.2 Prescription Trends, (2023), by Region
5.3 Drug Volume: Production and usage volumes of pharmaceuticals.
5.4 Healthcare Spending: Expenditure data by government, insurers, and out-of-pocket by patients.
6. Competitive Landscape
6.1 List of Major Companies, By Region
6.2 Market Share Analysis, By Region
6.3 Product Benchmarking
6.3.1 Product specifications and features
6.3.2 Pricing
6.4 Strategic Initiatives
6.4.1 Marketing and promotional activities
6.4.2 Distribution and supply chain strategies
6.4.3 Expansion plans and new Product launches
6.4.4 Strategic partnerships and collaborations
6.5 Technological Advancements
6.6 Market Positioning and Branding
7. Personalized Medicine Market Segmentation, by Product
7.1 Chapter Overview
7.2 Personalized Medicine Diagnostics
7.2.1 Personalized Medicine Diagnostics Market Trends Analysis (2020-2032)
7.2.2 Personalized Medicine Diagnostics Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3 Personalized Medicine Therapeutics
7.3.1 Personalized Medicine Therapeutics Market Trends Analysis (2020-2032)
7.3.2 Personalized Medicine Therapeutics Market Size Estimates and Forecasts to 2032 (USD Billion)
7.4 Personalized Medical Care
7.4.1 Personalized Medical Care Market Trends Analysis (2020-2032)
7.4.2 Personalized Medical Care Market Size Estimates and Forecasts to 2032 (USD Billion)
-
- Personalized Nutrition & Wellness
7.5.1 Personalized Nutrition & Wellness Market Trends Analysis (2020-2032)
7.5.2 Personalized Nutrition & Wellness Market Size Estimates and Forecasts to 2032 (USD Billion)
8. Personalized Medicine Market Segmentation, by End-use
8.1 Chapter Overview
8.2 Hospitals
8.2.1 Hospitals Market Trends Analysis (2020-2032)
8.2.2 Hospitals Market Size Estimates and Forecasts to 2032 (USD Billion)
8.3 Diagnostic Centers
8.3.1 Diagnostic Centers Market Trends Analysis (2020-2032)
8.3.2 Diagnostic Centers Market Size Estimates and Forecasts to 2032 (USD Billion)
8.4 Research & Academic Institutes
8.4.1 Research & Academic Institutes Market Trends Analysis (2020-2032)
8.4.2 Research & Academic Institutes Market Size Estimates and Forecasts to 2032 (USD Billion)
8.5 Others
8.5.1 Others Market Trends Analysis (2020-2032)
8.5.2 Others Market Size Estimates and Forecasts to 2032 (USD Billion)
9. Regional Analysis
9.1 Chapter Overview
9.2 North America
9.2.1 Trends Analysis
9.2.2 North America Personalized Medicine Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.2.3 North America Personalized Medicine Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.2.4 North America Personalized Medicine Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
9.2.5 USA
9.2.5.1 USA Personalized Medicine Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.2.5.2 USA Personalized Medicine Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
9.2.6 Canada
9.2.6.1 Canada Personalized Medicine Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.2.6.2 Canada Personalized Medicine Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
9.2.7 Mexico
9.2.7.1 Mexico Personalized Medicine Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.2.7.2 Mexico Personalized Medicine Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
9.3 Europe
9.3.1 Eastern Europe
9.3.1.1 Trends Analysis
9.3.1.2 Eastern Europe Personalized Medicine Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.3.1.3 Eastern Europe Personalized Medicine Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.3.1.4 Eastern Europe Personalized Medicine Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
9.3.1.5 Poland
9.3.1.5.1 Poland Personalized Medicine Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.3.1.5.2 Poland Personalized Medicine Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
9.3.1.6 Romania
9.3.1.6.1 Romania Personalized Medicine Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.3.1.6.2 Romania Personalized Medicine Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
9.3.1.7 Hungary
9.3.1.7.1 Hungary Personalized Medicine Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.3.1.7.2 Hungary Personalized Medicine Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
9.3.1.8 Turkey
9.3.1.8.1 Turkey Personalized Medicine Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.3.1.8.2 Turkey Personalized Medicine Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
9.3.1.9 Rest of Eastern Europe
9.3.1.9.1 Rest of Eastern Europe Personalized Medicine Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.3.1.9.2 Rest of Eastern Europe Personalized Medicine Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
9.3.2 Western Europe
9.3.2.1 Trends Analysis
9.3.2.2 Western Europe Personalized Medicine Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.3.2.3 Western Europe Personalized Medicine Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.3.2.4 Western Europe Personalized Medicine Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
9.3.2.5 Germany
9.3.2.5.1 Germany Personalized Medicine Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.3.2.5.2 Germany Personalized Medicine Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
9.3.2.6 France
9.3.2.6.1 France Personalized Medicine Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.3.2.6.2 France Personalized Medicine Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
9.3.2.7 UK
9.3.2.7.1 UK Personalized Medicine Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.3.2.7.2 UK Personalized Medicine Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
9.3.2.8 Italy
9.3.2.8.1 Italy Personalized Medicine Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.3.2.8.2 Italy Personalized Medicine Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
9.3.2.9 Spain
9.3.2.9.1 Spain Personalized Medicine Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.3.2.9.2 Spain Personalized Medicine Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
9.3.2.10 Netherlands
9.3.2.10.1 Netherlands Personalized Medicine Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.3.2.10.2 Netherlands Personalized Medicine Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
9.3.2.11 Switzerland
9.3.2.11.1 Switzerland Personalized Medicine Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.3.2.11.2 Switzerland Personalized Medicine Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
9.3.2.12 Austria
9.3.2.12.1 Austria Personalized Medicine Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.3.2.12.2 Austria Personalized Medicine Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
9.3.2.13 Rest of Western Europe
9.3.2.13.1 Rest of Western Europe Personalized Medicine Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.3.2.13.2 Rest of Western Europe Personalized Medicine Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
9.4 Asia Pacific
9.4.1 Trends Analysis
9.4.2 Asia Pacific Personalized Medicine Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.4.3 Asia Pacific Personalized Medicine Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.4.4 Asia Pacific Personalized Medicine Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
9.4.5 China
9.4.5.1 China Personalized Medicine Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.4.5.2 China Personalized Medicine Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
9.4.6 India
9.4.5.1 India Personalized Medicine Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.4.5.2 India Personalized Medicine Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
9.4.5 Japan
9.4.5.1 Japan Personalized Medicine Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.4.5.2 Japan Personalized Medicine Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
9.4.6 South Korea
9.4.6.1 South Korea Personalized Medicine Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.4.6.2 South Korea Personalized Medicine Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
9.4.7 Vietnam
9.4.7.1 Vietnam Personalized Medicine Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.2.7.2 Vietnam Personalized Medicine Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
9.4.8 Singapore
9.4.8.1 Singapore Personalized Medicine Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.4.8.2 Singapore Personalized Medicine Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
9.4.9 Australia
9.4.9.1 Australia Personalized Medicine Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.4.9.2 Australia Personalized Medicine Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
9.4.10 Rest of Asia Pacific
9.4.10.1 Rest of Asia Pacific Personalized Medicine Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.4.10.2 Rest of Asia Pacific Personalized Medicine Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
9.5 Middle East and Africa
9.5.1 Middle East
9.5.1.1 Trends Analysis
9.5.1.2 Middle East Personalized Medicine Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.5.1.3 Middle East Personalized Medicine Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.5.1.4 Middle East Personalized Medicine Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
9.5.1.5 UAE
9.5.1.5.1 UAE Personalized Medicine Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.5.1.5.2 UAE Personalized Medicine Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
9.5.1.6 Egypt
9.5.1.6.1 Egypt Personalized Medicine Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.5.1.6.2 Egypt Personalized Medicine Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
9.5.1.7 Saudi Arabia
9.5.1.7.1 Saudi Arabia Personalized Medicine Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.5.1.7.2 Saudi Arabia Personalized Medicine Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
9.5.1.8 Qatar
9.5.1.8.1 Qatar Personalized Medicine Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.5.1.8.2 Qatar Personalized Medicine Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
9.5.1.9 Rest of Middle East
9.5.1.9.1 Rest of Middle East Personalized Medicine Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.5.1.9.2 Rest of Middle East Personalized Medicine Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
9.5.2 Africa
9.5.2.1 Trends Analysis
9.5.2.2 Africa Personalized Medicine Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.5.2.3 Africa Personalized Medicine Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.5.2.4 Africa Personalized Medicine Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
9.5.2.5 South Africa
9.5.2.5.1 South Africa Personalized Medicine Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.5.2.5.2 South Africa Personalized Medicine Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
9.5.2.6 Nigeria
9.5.2.6.1 Nigeria Personalized Medicine Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.5.2.6.2 Nigeria Personalized Medicine Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
9.5.2.7 Rest of Africa
9.5.2.7.1 Rest of Africa Personalized Medicine Market Estimates and Forecasts, by Component (2020-2032) (USD Billion)
9.5.2.7.2 Rest of Africa Personalized Medicine Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
9.6 Latin America
9.6.1 Trends Analysis
9.6.2 Latin America Personalized Medicine Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.6.3 Latin America Personalized Medicine Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.6.4 Latin America Personalized Medicine Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
9.6.5 Brazil
9.6.5.1 Brazil Personalized Medicine Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.6.5.2 Brazil Personalized Medicine Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
9.6.6 Argentina
9.6.6.1 Argentina Personalized Medicine Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.6.6.2 Argentina Personalized Medicine Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
9.6.7 Colombia
9.6.7.1 Colombia Personalized Medicine Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.6.7.2 Colombia Personalized Medicine Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
9.6.8 Rest of Latin America
9.6.8.1 Rest of Latin America Personalized Medicine Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.6.8.2 Rest of Latin America Personalized Medicine Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
10. Company Profiles
10.1 GE Healthcare
10.1.1 Company Overview
10.1.2 Financial
10.1.3 Products/ Services Offered
110.1.4 SWOT Analysis
10.2 Illumina, Inc.
10.2.1 Company Overview
10.2.2 Financial
10.2.3 Products/ Services Offered
10.2.4 SWOT Analysis
10.3 ASURAGEN, INC.
10.3.1 Company Overview
10.3.2 Financial
10.3.3 Products/ Services Offered
10.3.4 SWOT Analysis
10.4 Abbott
10.4.1 Company Overview
10.4.2 Financial
10.4.3 Products/ Services Offered
10.4.4 SWOT Analysis
10.5 Dako A/S
10.5.1 Company Overview
10.5.2 Financial
10.5.3 Products/ Services Offered
10.5.4 SWOT Analysis
10.6 Exact Sciences Corporation
10.6.1 Company Overview
10.6.2 Financial
10.6.3 Products/ Services Offered
10.6.4 SWOT Analysis
10.7 Danaher Corporation (Cepheid, Inc.)
10.7.1 Company Overview
10.7.2 Financial
10.7.3 Products/ Services Offered
10.7.4 SWOT Analysis
10.8 Decode Genetics, Inc.
10.8.1 Company Overview
10.8.2 Financial
10.8.3 Products/ Services Offered
10.8.4 SWOT Analysis
10.9 QIAGEN
10.9.1 Company Overview
10.9.2 Financial
10.9.3 Products/ Services Offered
10.9.4 SWOT Analysis
10.10 Exagen Inc.
10.9.1 Company Overview
10.9.2 Financial
10.9.3 Products/ Services Offered
10.9.4 SWOT Analysis
11. Use Cases and Best Practices
12. Conclusion
